How treatment monitoring is influencing treatment decisions in glioblastomas

Current Treatment Options in Neurology
Martha R NeaguPatrick Y Wen

Abstract

Glioblastoma (GBM), the most common malignant primary tumor in adults, carries a dismal prognosis with an average median survival of 14-16 months. The current standard of care for newly diagnosed GBM consists of maximal safe resection followed by fractionated radiotherapy combined with concurrent temozolomide and 6 to 12 cycles of adjuvant temozolomide. The determination of treatment response and clinical decision-making in the treatment of GBM depends on accurate radiographic assessment. Differentiating treatment response from tumor progression is challenging and combines long-term follow-up using standard MRI, with assessing clinical status and corticosteroid dependency. At progression, bevacizumab is the mainstay of treatment. Incorporation of antiangiogenic therapies leads to rapid blood-brain barrier normalization with remarkable radiographic response often not accompanied by the expected survival benefit, further complicating imaging assessment. Improved radiographic interpretation criteria, such as the Response Assessment in Neuro-Oncology (RANO) criteria, incorporate non-enhancing disease but still fall short of definitely distinguishing tumor progression, pseudoresponse, and pseudoprogression. With new evolving treatme...Continue Reading

References

Nov 18, 1971·The New England Journal of Medicine·J Folkman
Apr 3, 2002·European Journal of Nuclear Medicine and Molecular Imaging·June-Key ChungMyung Chul Lee
Mar 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W RoaP Forsyth
Aug 17, 2004·European Journal of Nuclear Medicine and Molecular Imaging·Koen Van LaereLuc Mortelmans
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Mar 11, 2005·The New England Journal of Medicine·Monika E HegiRoger Stupp
Feb 17, 2006·Acta neurochirurgica·M WestphalUNKNOWN Executive Committee of the Gliadel Study Group
Apr 13, 2007·The New England Journal of Medicine·Florence Keime-GuibertUNKNOWN Association of French-Speaking Neuro-Oncologists
Jun 7, 2007·Proceedings of the National Academy of Sciences of the United States of America·Eilon D KirsonYoram Palti
Jan 4, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Manuel Gómez-RíoJosé Manuel Llamas-Elvira
May 3, 2008·The Lancet Oncology·Dieta BrandsmaMartin J van den Bent
Aug 2, 2008·The New England Journal of Medicine·Patrick Y Wen, Santosh Kesari
Dec 2, 2008·Journal of Neuro-oncology·Andrew D NordenPatrick Y Wen
Dec 31, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Teri N KreislHoward A Fine
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin J van den BentSusan M Chang
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henry S FriedmanTimothy Cloughesy
Nov 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jedd D WolchokF Stephen Hodi
Mar 17, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick Y WenSusan M Chang
Apr 7, 2010·Neuro-oncology·Luc BauchetUNKNOWN Association des Neuro-Oncologues d'Expression Française (ANOCEF)
May 12, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tracy T BatchelorRakesh K Jain
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Jul 22, 2010·International Journal of Radiation Oncology, Biology, Physics·Marc D PirothMichael J Eble
Sep 8, 2010·The New England Journal of Medicine·Philip W KantoffUNKNOWN IMPACT Study Investigators
Feb 8, 2011·PloS One·Charles W KanalyJohn H Sampson
May 12, 2011·Neuro-oncology·Jeffrey S WefelHenry S Friedman
May 20, 2011·Nature·Peter Carmeliet, Rakesh K Jain
Nov 26, 2011·AJNR. American Journal of Neuroradiology·C P GeerA J Johnson

❮ Previous
Next ❯

Citations

Dec 25, 2019·The Cochrane Database of Systematic Reviews·Gerard ThompsonMichael D Jenkinson
Sep 7, 2017·Expert Review of Molecular Diagnostics·Ganesh M ShankarBob S Carter
Sep 19, 2015·Journal of Translational Medicine·Jennifer JohnsonQian Xie
Dec 1, 2021·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Jessy Van van AsperenElly Hol

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

© 2022 Meta ULC. All rights reserved